CN Energy Group faces Nasdaq delisting after bid price failure highlights structural limits of repeated reverse splits
CN Energy Group faces a Nasdaq delisting notice after repeated reverse splits and sub-$1 pricing. Discover what this means for investors and microcap governance.
Why the latest winter storm is disrupting U.S. power grids and aviation networks at national scale
Find out why Winter Storm Fern is disrupting U.S. power grids and airlines nationwide and what it reveals about infrastructure resilience risks.
How Eaton’s $1.55bn Ultra PCS deal reshapes its aerospace segment economics and long-cycle defense positioning
Discover how Eaton’s $1.55B Ultra PCS acquisition reshapes aerospace defense margins and long-term strategy. Find out what this means for investors.
What CenterPoint Energy’s winter storm response reveals about Houston’s grid risk before the next hard freeze
CenterPoint Energy restores power to over 99 percent of customers as winter weather tests Houston’s grid resilience. Find out what the next freeze could reveal.
PDS Biotechnology Corporation strengthens PDS0101 intellectual property ahead of key regulatory milestones
PDS Biotechnology strengthens PDS0101 patent protection ahead of key Phase 3 and regulatory milestones. Find out what this means for investors.
Telehealth distribution becomes central to 60 Degrees Pharmaceuticals’ malaria prevention execution plan
60 Degrees Pharmaceuticals partners with Runway Health to expand ARAKODA access. Explore what this telehealth shift means for growth and execution.
U.S. Department of Veterans Affairs awards EsoGuard contract to Lucid Diagnostics
Explore how Lucid Diagnostics’ VA contract validates EsoGuard, shaping investor sentiment, competitive positioning, and nationwide adoption of non-invasive cancer diagnostics.
What Erayak Power Solution Group Inc.’s storm-driven sales surge reveals about U.S. grid anxiety
Discover how Erayak Power Solution Group Inc.’s winter storm demand surge is reshaping its U.S. strategy and what it means for investors.
What the Openmarkets–Lake Superior Acquisition Corp deal reveals about fintech IPO timing in 2026
Openmarkets plans a Nasdaq listing via a SPAC merger with Lake Superior Acquisition Corp. Find out how its DeFi and tokenisation strategy could reshape fintech growth.
Ateganosine Phase 3 marks inflection point for MAIA Biotechnology with 2026 milestones in focus
Find out how MAIA Biotechnology’s Phase 3 ateganosine trial and 2026 milestones could reshape its regulatory path and investor narrative.